ETFis Series Trust I (BBC)
Management Company · ARCX · Series S000047353 · View on SEC EDGAR ↗
- Net assets
- $37.3M
- Holdings
- 125
- As of
- April 30, 2026 stale
- Top 10 holdings weight
- 17.13%
- Effective number of positions
- 98.9
- Positions above 1%
- 27
On this page
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
Fund flows (SEC-reported)
- Last month (Apr 2026)
- +$175K
- Quarter ending Apr 2026
- -$1.8M
- Trailing 12 months
- +$5.5M
May 2025 – Apr 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 125 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| DREYFUS GOVERNMENT CASH MANAGE | — | $852K | 2.28 | 852,188 | STIV | US |
| ERASCA INC | 29479A108 | $817K | 2.19 | 76,668 | EC | US |
| ENLIVEN THERAPEUTICS INC | 29337E102 | $675K | 1.81 | 16,370 | EC | US |
| TANGO THERAPEUTICS INC | 87583X109 | $638K | 1.71 | 29,518 | EC | US |
| ORUKA THERAPEUTICS INC | 687604108 | $625K | 1.68 | 9,143 | EC | US |
| SPYRE THERAPEUTICS INC | 00773J202 | $611K | 1.64 | 8,208 | EC | US |
| ALUMIS INC | 022307102 | $593K | 1.59 | 24,020 | EC | US |
| DIANTHUS THERAPEUTICS INC | 252828108 | $575K | 1.54 | 6,551 | EC | US |
| KODIAK SCIENCES INC | 50015M109 | $504K | 1.35 | 11,591 | EC | US |
| REVOLUTION MEDICINES INC | 76155X100 | $504K | 1.35 | 3,496 | EC | US |
| CORVUS PHARMACEUTICALS INC | 221015100 | $501K | 1.34 | 32,976 | EC | US |
| REZOLUTE INC | 76200L309 | $491K | 1.31 | 153,338 | EC | US |
| DEFINIUM THERAPEUTICS INC | 24477V105 | $481K | 1.29 | 21,993 | EC | CA |
| CG ONCOLOGY INC | 156944100 | $450K | 1.21 | 6,741 | EC | US |
| JADE BIOSCIENCES INC | 008064206 | $450K | 1.20 | 18,425 | EC | US |
| INHIBRX BIOSCIENCES INC | 45720N103 | $448K | 1.20 | 3,467 | EC | US |
| RELAY THERAPEUTICS INC | 75943R102 | $445K | 1.19 | 34,371 | EC | US |
| GH RESEARCH PLC | — | $435K | 1.16 | 21,175 | EC | IE |
| NEKTAR THERAPEUTICS | 640268306 | $429K | 1.15 | 5,045 | EC | US |
| TYRA BIOSCIENCES INC | 90240B106 | $424K | 1.14 | 12,196 | EC | US |
| VIR BIOTECHNOLOGY INC | 92764N102 | $421K | 1.13 | 41,256 | EC | US |
| INTELLIA THERAPEUTICS INC | 45826J105 | $412K | 1.10 | 30,599 | EC | US |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | $410K | 1.10 | 10,411 | EC | GB |
| ANAPTYSBIO INC | 032724106 | $404K | 1.08 | 6,139 | EC | US |
| OMEROS CORP | 682143102 | $397K | 1.06 | 27,192 | EC | US |
| TECTONIC THERAPEUTIC INC | 878972108 | $391K | 1.05 | 13,966 | EC | US |
| ALLOGENE THERAPEUTICS INC | 019770106 | $389K | 1.04 | 182,788 | EC | US |
| COMPASS PATHWAYS PLC | 20451W101 | $371K | 0.99 | 40,950 | EC | GB |
| EDGEWISE THERAPEUTICS INC | 28036F105 | $362K | 0.97 | 11,685 | EC | US |
| PALVELLA THERAPEUTICS INC | 697947109 | $359K | 0.96 | 2,798 | EC | US |
| CAPRICOR THERAPEUTICS INC | 14070B309 | $356K | 0.95 | 10,606 | EC | US |
| VAXCYTE INC | 92243G108 | $355K | 0.95 | 6,201 | EC | US |
| PHARVARIS NV | — | $354K | 0.95 | 11,424 | EC | NL |
| ARRIVENT BIOPHARMA INC | 04272N102 | $351K | 0.94 | 11,300 | EC | US |
| XENON PHARMACEUTICALS INC | 98420N105 | $351K | 0.94 | 6,264 | EC | CA |
| NEUROGENE INC | 64135M105 | $344K | 0.92 | 13,193 | EC | US |
| SUMMIT THERAPEUTICS INC | 86627T108 | $337K | 0.90 | 15,708 | EC | US |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | $337K | 0.90 | 21,068 | EC | US |
| CELLDEX THERAPEUTICS INC | 15117B202 | $330K | 0.88 | 10,032 | EC | US |
| PRAXIS PRECISION MEDICINES INC | 74006W207 | $327K | 0.88 | 1,026 | EC | US |
| ARCUS BIOSCIENCES INC | 03969F109 | $327K | 0.88 | 12,819 | EC | US |
| ANNEXON INC | 03589W102 | $326K | 0.87 | 55,535 | EC | US |
| TERNS PHARMACEUTICALS INC | 880881107 | $325K | 0.87 | 6,132 | EC | US |
| LIQUIDIA CORP | 53635D202 | $324K | 0.87 | 8,268 | EC | US |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | $324K | 0.87 | 16,922 | EC | US |
| IMMUNOME INC | 45257U108 | $323K | 0.87 | 14,102 | EC | US |
| BICARA THERAPEUTICS INC | 055477103 | $322K | 0.86 | 14,934 | EC | US |
| CELCUITY INC | 15102K100 | $318K | 0.85 | 2,621 | EC | US |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | $318K | 0.85 | 77,097 | EC | US |
| ABCELLERA BIOLOGICS INC | 00288U106 | $316K | 0.85 | 76,245 | EC | CA |
Page 1
of 3
← Previous
Next →
Sector breakdown
Healthcare
88.9%
Other/Unmapped
11.1%
Institutional owners (13F) 20 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| Kera Capital Partners, Inc. | $5,321,454 | 25.26% | 101,003 | Shares | June 30, 2026 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $3,643,703 | 17.30% | 68,536 | Shares | June 30, 2026 |
| Militia Capital Management LLC | $2,405,805 | 11.42% | 45,663 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $2,251,593 | 10.69% | 42,736 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,052,650 | 9.75% | 38,960 | Shares | June 30, 2026 |
| Quantinno Capital Management LP | $1,212,254 | 5.76% | 23,009 | Shares | June 30, 2026 |
| Militia Capital Partners, LP | $1,205,501 | 5.72% | 31,263 | Shares | Dec. 31, 2025 |
| MORGAN STANLEY | $791,609 | 3.76% | 15,025 | Shares | June 30, 2026 |
| LPL Financial LLC | $649,567 | 3.08% | 12,329 | Shares | June 30, 2026 |
| GOLDMAN SACHS GROUP INC | $456,999 | 2.17% | 8,674 | Shares | June 30, 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $234,348 | 1.11% | 4,448 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $221,610 | 1.05% | 4,206 | Shares | June 30, 2026 |
| Worth Asset Management, LLC | $215,644 | 1.02% | 4,093 | Shares | June 30, 2026 |
| Operose Advisors LLC | $119,808 | 0.57% | 2,274 | Shares | June 30, 2026 |
| UBS Group AG | $110,430 | 0.52% | 2,096 | Shares | June 30, 2026 |
| Institute for Wealth Management, LLC. | $99,577 | 0.47% | 1,890 | Shares | June 30, 2026 |
| Dynamic Wealth Strategies, LLC | $48,840 | 0.23% | 927 | Shares | June 30, 2026 |
| GROUP ONE TRADING LLC | $15,806 | 0.08% | 300 | Shares | June 30, 2026 |
| Federation des caisses Desjardins du Quebec | $5,795 | 0.03% | 110 | Shares | June 30, 2026 |
| Allworth Financial LP | $527 | 0.00% | 10 | Shares | June 30, 2026 |
Peer funds
Similar by size
| Fund | AUM |
|---|---|
| FMNY First Trust Exchange-Traded Fun… | $37.4M |
| TYD Direxion Shares ETF Trust | $37.6M |
| RSSE First Trust Exchange-Traded Fun… | $37.6M |
| OVM Listed Funds Trust | $38.0M |
| ASHS DBX ETF Trust | $38.3M |
| GRZZ Tidal Trust II | $37.2M |
| GFGF EA Series Trust | $37.1M |
| NRES DBX ETF Trust | $37.0M |
| FTBD Fidelity Merrimack Street Trust | $36.9M |
| XISE First Trust Exchange-Traded Fun… | $36.6M |